| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2016-10-03 |
详情>>
内部人交易：
ASHMAN HARVEY A.等共交易32笔
|
| 2016-08-17 |
股东大会：
将于2016-09-22召开股东大会
会议内容 ▼▲
- 1.to consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated as of May 3, 2016, by and between Quintiles Transnational Holdings Inc. (“Quintiles”), a North Carolina corporation, and IMS Health (the “merger agreement”), a copy of which is included as Appendix A to the joint proxy statement/prospectus of which this notice is a part, which is conditioned on the proposal regarding the approval of the elimination of the supermajority voting requirement to amend certain provisions of the Delaware certificate of incorporation and the proposal regarding the authorized common stock contained in the Delaware certificate of incorporation;
2.to consider and vote on the proposal to approve the elimination of the supermajority voting requirement to amend certain provisions of the Delaware certificate of incorporation of Quintiles as the surviving corporation in the merger, a copy of which is included as Appendix D to the joint proxy statement/prospectus of which this notice is a part, which is conditioned on the adoption of the merger agreement and the proposal regarding the authorized common stock contained in the Delaware certificate of incorporation;
3.to consider and vote on the proposal to approve the authorized number of shares of common stock contained in the Delaware certificate of incorporation, a copy of which is included as Appendix D to the joint proxy statement/prospectus of which this notice is a part, which is conditioned on the adoption of the merger agreement and the proposal regarding the approval of the elimination of the supermajority voting requirement to amend certain provisions of the Delaware certificate of incorporation;
4.to consider and vote on the proposal to approve, on an advisory (non-binding) basis, specific compensatory arrangements between IMS Health and its named executive officers relating to the merger with Quintiles, as described in the joint proxy statement/prospectus of which this notice is a part;
5.to consider and vote on the proposal to adjourn the IMS Health special meeting, if necessary or appropriate, to solicit additional proxies for any proposal if there are not sufficient votes to approve IMS Health Proposals Nos. 1, 2 and 3.
|
| 2016-08-17 |
详情>>
股本变动：
变动后总股本32959.88万股
|
| 2016-07-28 |
详情>>
业绩披露：
2016年中报每股收益0.20美元,归母净利润6700.00万美元,同比去年增长-80.58%
|
| 2016-05-06 |
详情>>
业绩披露：
2016年一季报每股收益0.13美元,归母净利润4300.00万美元,同比去年增长-85.57%
|
| 2016-02-22 |
股东大会：
将于2016-04-08召开股东大会
会议内容 ▼▲
- 1.Election of Class II directors whose term will expire in 2016
2.Ratification of our Audit Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2016
|
| 2016-02-19 |
详情>>
业绩披露：
2015年年报每股收益1.26美元,归母净利润4.17亿美元,同比去年增长320.63%
|
| 2016-02-19 |
详情>>
业绩披露：
2013年年报每股收益0.29美元,归母净利润8200.00万美元,同比去年增长295.24%
|
| 2015-11-04 |
详情>>
业绩披露：
2015年三季报(累计)每股收益1.17美元,归母净利润3.88亿美元,同比去年增长296.95%
|
| 2015-08-04 |
详情>>
业绩披露：
2015年中报每股收益1.03美元,归母净利润3.45亿美元,同比去年增长241.39%
|
| 2015-05-15 |
详情>>
业绩披露：
2015年一季报每股收益0.89美元,归母净利润2.98亿美元,同比去年增长1341.67%
|
| 2015-03-03 |
股东大会：
将于2015-04-21召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors for a three-year term
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2015
3.To vote on an advisory, non-binding resolution to approve the compensation of the Company’s named executive officers (“say-on-pay”)
4.To vote on an advisory, non-binding proposal as to whether “say-on-pay” votes should be held every one, two or three years
5.To transact any other business that may properly come before the meeting.
|
| 2015-02-13 |
详情>>
业绩披露：
2014年年报每股收益-0.59美元,归母净利润-1.89亿美元,同比去年增长-330.49%
|